Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

NCT00741637 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Cholera
Vibrio Infections
Diarrhea

Interventions

BIOLOGICAL: CholeraGarde®
BIOLOGICAL: Placebo

Sponsor

International Vaccine Institute

Collaborators

[object Object]
[object Object]